Saturday 17 October 2026
Export CGC’s income statement to Excel — free account
Canopy Growth Corporation
CGC Healthcare Drug Manufacturers Specialty & Generic
Canopy Growth Corporation’s revenue for fiscal 2026 (year ended March 2026) was $206.0 million, up 6.55% from fiscal 2025. In the quarter to June 2026, revenue grew 12.4%, EPS grew 87.5%, free cash flow fell 117.6% and total debt fell 18.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years, operating cash flow growth for three.
0.71
0.03
−4.05%
Follow CGC
| Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 4 | 5 | 4 | 2 | 4 | 2 | 2 | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(13.21) | (16.35) | (10.69) | (8.72) | (0.70) | 1.51 | 1.04 | 6.45 | 18.57 | 12.22 |
P/S ratio |
1.37 | 0.51 | 2.56 | 2.66 | 7.15 | 28.73 | 16.74 | 56.31 | 31.64 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(29.51) | (37.06) | (25.73) | (19.56) | (1.35) | (0.57) | 1.43 | 7.87 | 7.92 | 11.52 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
(3.49) | (4.71) | (4.49) | — | — | (4.36) | — | (0.66) | (1.24) | — |
P/Operating CF |
(20.96) | (4.01) | (31.04) | (7.14) | (28.83) | (168.58) | (30.32) | (65.31) | (154.41) | (57.00) |
P/B ratio |
0.56 | 0.28 | 1.52 | 1.41 | 1.03 | 4.51 | 1.31 | 2.06 | 4.54 | 2.51 |
Price to Tangible BV |
0.71 | 0.38 | 2.15 | 2.21 | 2.52 | 12.19 | 2.49 | 2.87 | 6.82 | 7.32 |
EV/Sales |
0.90 | 1.12 | 3.86 | 3.93 | 7.37 | 27.40 | 12.90 | 42.80 | 29.88 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(3.99) | (1.82) | (4.07) | (2.84) | (7.03) | (32.16) | (6.66) | (21.74) | (65.35) | 0.00 |
EV/FCF |
(3.65) | (1.76) | (8.69) | (2.86) | (6.77) | (26.02) | (3.44) | (9.40) | (20.52) | 0.00 |
Quick Ratio |
2.56 | 2.02 | 1.12 | 1.11 | 6.95 | 8.45 | 4.96 | 11.23 | 3.74 | 6.12 |
Current Ratio |
3.34 | 3.12 | 1.58 | 1.34 | 8.16 | 9.98 | 6.10 | 12.32 | 5.24 | 10.06 |
Net Debt/EBITDA |
1.09 | (2.25) | (2.20) | (0.19) | (0.12) | 0.65 | 0.99 | 6.73 | 4.97 | 10.06 |
Debt/Assets |
20.86% | 33.13% | 45.93% | 53.58% | 26.73% | 23.20% | 6.79% | 10.83% | 0.59% | 1.52% |
Debt/Equity |
0.33 | 0.62 | 1.19 | 1.72 | 0.42 | 0.45 | 0.09 | 0.13 | 0.01 | 0.02 |
Asset Turnover |
0.28 | 0.24 | 0.16 | 0.10 | 0.09 | 0.08 | 0.05 | 0.05 | 0.17 | 0.30 |
Operating CF/Net income |
0.24 | 0.28 | 0.43 | 0.17 | 1.81 | 0.27 | 0.58 | 0.76 | 1.16 | 1.63 |
Capex/Depreciation |
(0.16) | (0.15) | 2.82 | 0.04 | (0.18) | (0.86) | (5.77) | (14.55) | (8.69) | (4.86) |
Interest Coverage |
— | — | — | (120.68) | (163.57) | (55.57) | (27.05) | (11.95) | (62.44) | (230.43) |
| (44.51%) | (119.21%) | (103.01%) | (144.08%) | (8.75%) | (40.80%) | (21.23%) | (16.10%) | (7.63%) | (4.49%) | |
| (25.90%) | (52.96%) | (34.69%) | (78.42%) | (5.00%) | (25.61%) | (16.82%) | (13.44%) | (6.71%) | (4.90%) | |
ROIC |
(18.00%) | (11.21%) | (16.12%) | (139.89%) | (18.23%) | (28.17%) | (29.17%) | (9.82%) | (5.63%) | (1.82%) |
Return on Tangible Assets |
(38.24%) | (121.15%) | (143.96%) | (424.15%) | (12.25%) | (48.09%) | (36.02%) | (11.91%) | (10.15%) | (6.48%) |
Average Days of Receivables |
46.54 | 71.62 | 63.69 | 85.15 | 67.65 | 61.72 | 82.52 | 147.70 | 43.87 | 21.23 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.76% | 0.82% | 0.81% |
Selling, General and Administrative Expense of Revenue |
57.71% | 61.50% | 81.98% | 120.97% | 99.99% | 121.93% | 254.28% | 229.17% | 73.56% | 38.57% |
Intangible Assets out of Total Assets |
0.13 | 0.15 | 0.11 | 0.11 | 0.38 | 0.32 | 0.35 | 0.24 | 0.29 | 0.60 |
Share Based Compensation of Revenue |
1.50% | (1.56%) | 4.77% | 7.74% | 9.13% | 16.67% | 80.32% | 108.86% | 28.71% | 10.05% |
Graham Net Nets |
0.28 | (1.00) | (0.56) | (0.56) | (0.08) | (0.03) | 0.12 | 0.24 | 0.05 | 0.07 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(61.51%) | (443.96%) | (84.73%) | (332.00%) | (7.39%) | (11.27%) | (20.86%) | (4.80%) | (1.08%) | (1.38%) |
Free Cash Flow Yield |
(17.83%) | (126.37%) | (17.36%) | (51.69%) | (15.24%) | (3.66%) | (22.39%) | (8.08%) | (4.60%) | 0.00% |
Revenue per Share |
0.69 | 1.80 | 2.95 | 6.57 | 10.61 | 11.15 | 8.61 | 7.54 | 7.84 | 6.40 |
Operating CF per Share |
(0.15) | (1.11) | (2.79) | (9.10) | (11.13) | (9.50) | (16.69) | (14.86) | (3.59) | (1.73) |
Capex per Share |
(0.01) | (0.04) | 1.49 | 0.05 | (0.42) | (2.24) | (15.59) | (19.49) | (7.84) | (1.89) |
Free Cash Flow per Share |
(0.17) | (1.15) | (1.31) | (9.05) | (11.55) | (11.74) | (32.28) | (34.34) | (11.42) | (3.62) |
Cash per Share |
0.90 | 0.92 | 2.09 | 12.96 | 28.21 | 47.12 | 43.16 | 128.86 | 14.19 | 6.55 |
Shareholders Equity per Share |
1.69 | 3.26 | 4.96 | 12.40 | 73.28 | 71.10 | 110.34 | 206.67 | 54.71 | 39.36 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.69 | 3.26 | 4.96 | 12.40 | 73.28 | 71.10 | 110.34 | 206.67 | 54.71 | 39.36 |
Free Cash Flow |
(50.49) | (123.69) | (97.77) | (419.47) | (452.07) | (436.26) | (1,123.59) | (916.88) | (202.54) | (43.11) |
Working Capital |
268.55 | 143.86 | 101.16 | 206.84 | 1,216.25 | 1,935.57 | 1,611.70 | 3,549.76 | 304.08 | 121.92 |
Capital Expenditures |
(4.31) | (4.56) | 111.24 | 2.31 | (16.62) | (83.28) | (542.73) | (520.25) | (138.95) | (22.47) |
Net Current Asset Value |
78.41 | (97.68) | (317.75) | (455.28) | (226.06) | (378.01) | 612.53 | 2,727.80 | 224.85 | 87.48 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.02 | (0.50) | (0.01) | 0.04 | 0.20 | 1.81 | 2.58 | 1.00 | 0.30 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.12 | 0.15 | 0.17 | 0.17 | 0.12 | 0.12 | 0.08 | 0.04 | 0.07 | 0.06 |
Cash ROIC |
(5.36%) | (18.52%) | (10.08%) | (19.38%) | (8.75%) | (7.80%) | (19.74%) | (9.47%) | (16.49%) | (7.78%) |
Accounts Receivable Turnover |
6.42 | 5.06 | 4.02 | 4.12 | 5.65 | 6.01 | 4.02 | 4.10 | 13.15 | 29.27 |
Accounts Payable Turnover |
7.08 | 6.81 | 4.06 | 7.04 | 11.13 | 5.06 | 2.44 | 1.10 | 1.99 | 6.90 |
Inventory Turnover |
2.08 | 2.15 | 1.89 | 2.78 | 2.58 | 1.27 | 1.17 | 0.76 | 1.18 | 1.56 |
Average Days of Payables |
59.13 | 50.27 | 48.39 | 54.88 | 32.88 | 51.18 | 104.63 | 471.34 | 314.18 | 90.11 |
Days of Inventory on Hand |
187.67 | 185.64 | 130.45 | 107.19 | 104.57 | 280.00 | 331.62 | 709.67 | 413.75 | 349.19 |
Average Receivables |
32.10 | 38.18 | 54.77 | 74.02 | 73.50 | 68.92 | 74.65 | 49.12 | 10.57 | 2.60 |
Average Payables |
21.98 | 20.01 | 39.46 | 54.47 | 51.13 | 71.87 | 132.69 | 121.25 | 40.80 | 6.88 |
Average Inventory |
74.63 | 63.28 | 84.97 | 137.85 | 220.98 | 286.45 | 276.96 | 175.97 | 68.73 | 30.46 |
Average Assets |
734.64 | 811.74 | 1,404.56 | 3,162.43 | 4,825.60 | 5,163.58 | 5,904.64 | 3,887.32 | 818.60 | 258.10 |
Average Common Equity |
427.54 | 360.59 | 472.99 | 1,721.24 | 2,754.98 | 3,241.36 | 4,679.13 | 3,243.98 | 719.14 | 282.05 |
Columns are period end dates